Workflow
icon
Search documents
Why is ONEOK (OKE) One of the Most Profitable NYSE Stocks to Invest In?
Yahoo Finance· 2026-03-31 15:06
ONEOK, Inc. (NYSE:OKE) is one of the most profitable NYSE stocks to invest in. ONEOK, Inc. (NYSE:OKE) was upgraded to Overweight from Equal Weight by Wells Fargo on March 25, with the firm lifting the price target on the stock to $100 from $81. The firm believes that the Iran war will create a "structural shift" in global energy markets, including midstream, and will also boost demand for U.S. energy. It further told investors in a research note that it anticipates Permian gas and natural gas liquids supply ...
Truist Initiates Coverage of Range Resources Corporation (RRC) With a Hold Rating
Yahoo Finance· 2026-03-31 15:06
Range Resources Corporation (NYSE:RRC) is one of the most profitable NYSE stocks to invest in. Truist initiated coverage of Range Resources Corporation (NYSE:RRC) with a Hold rating on March 23, setting a price target of $48. The firm told investors that it likes the stock's story that revolves around capital-efficient growth over the next several years, capitalizing on incremental processing capacity and freed-up egress. However, Truist also argued that these attributes are already embedded in the stock pr ...
Coeur Mining (CDE) Gets Upgraded to Outperform From Sector Perform by ATB Capital
Yahoo Finance· 2026-03-31 15:06
Disclosure: None. Follow Insider Monkey on Google News. Why Coeur Mining, Inc. (CDE) Soared On Wednesday Coeur Mining, Inc. (NYSE:CDE) explores and develops gold and silver mines and mining properties in the US, Canada, and Mexico. It operates through the Palmarejo, Rochester, Kensington, Wharf, and Other segments. The Palmarejo segment manages a gold-silver complex, while the Rochester segment operates a silver-gold mine in northwestern Nevada. Similarly, the Kensington and Wharf segments operate an underg ...
Truist Initiates Coverage of EQT Corporation (EQT) With a Buy Rating and $74 PT
Yahoo Finance· 2026-03-31 15:06
EQT Corporation (NYSE:EQT) is one of the most profitable NYSE stocks to invest in. Truist initiated coverage of EQT Corporation (NYSE:EQT) with a Buy rating and $74 price target on March 23, telling investors in a research note that the company "stands out" as the largest Appalachian pure-play natural gas levered exploration and production company that holds core acreage in Pennsylvania, West Virginia, and Ohio targeting the Marcellus Shale. It further stated that EQT Corporation (NYSE:EQT) is best position ...
Vertiv Holdings (VRT) Announces Four New or Expanding Manufacturing Facilities in the Americas
Yahoo Finance· 2026-03-31 15:05
Disclosure: None. Follow Insider Monkey on Google News. Vertiv Holdings Co (VRT) Will Benefit From Data Center Spending, Says Jim Cramer While we acknowledge the potential of VRT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 15 Stocks That ...
BMO Capital Cuts PT on TPG Inc. (TPG) to $48 From $60 – Here’s Why
Yahoo Finance· 2026-03-31 15:05
TPG Inc. (NASDAQ:TPG) is one of the best affordable stocks to buy with good earnings growth. On March 24, BMO Capital cut the price target on TPG Inc. (NASDAQ:TPG) to $48 from $60, reiterating an Outperform rating on the shares. The rating update came as part of a broader research note on Alternative Asset Manager names, with the firm telling investors that issues are piling up, with uncertainty around realizations increasing with credit issues at Asset-Based Finance markets, BDC redemptions, AI-driven disr ...
Astera's Next Phase Begins Now
Seeking Alpha· 2026-03-31 15:05
I think the market has gotten the story wrong on Astera Labs, Inc. ( ALAB ), but not in a way most people would think. Since my last coverage, ALAB is down 23%, butHi, I'm Yiannis. Spotting winners before they break out is what I do best.Experience: Previously worked at Deloitte and KPMG in external/internal auditing and consulting. Education: Chartered Certified Accountant, Fellow Member of ACCA Global, with BSc and MSc degrees from U.K. business schools. Investment Style: Spotting high-potential winners b ...
Here are 2 things that  will trigger the next market wipeout, according to strategist
Finbold· 2026-03-31 15:05
A market strategist has warned that a potential market reset may be closer than many investors expect, with key structural and macroeconomic forces aligning.According to Chris Vermeulen, chief market strategist at The Technical Traders, this downturn will mainly be triggered by two major catalysts that could worsen market conditions.Speaking during an interview with David Lin published on March 31, Vermeulen pointed out that one of the deeper, longer-term forces is the rapid rise of artificial intelligence ...
Unilever confirms $44.8B acquisition of McCormick
Proactiveinvestors NA· 2026-03-31 15:02
About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...
Looking Ahead To Applied Digital's Q3 Earnings: Is The $2.4B Power Build Worth It?
Seeking Alpha· 2026-03-31 15:02
3Q26 earnings are set to come on April 8th for Applied Digital ( APLD ). I'm going to take a look ahead to those earnings in terms of what we can expect. My bull thesis hereI hold a Master’s degree in Cell Biology and began my career working for several years as a lab technician in a drug discovery clinic, where I gained extensive hands-on experience in cell culture, assay development, and therapeutic research. That scientific foundation gave me an appreciation for the rigor and challenges behind drug devel ...